EBOS Group Limited (ASX:EBO)

Market Cap	7.22B
Revenue (ttm)	12.60B
Net Income (ttm)	245.86M
Shares Out	n/a
EPS (ttm)	1.27
PE Ratio	29.36
Forward PE	24.64
Dividend	1.13 (3.14%)
Ex-Dividend Date	Feb 27, 2025

Volume	81,355
Average Volume	67,909
Open	35.84
Previous Close	35.75
Day's Range	35.59 - 36.52
52-Week Range	28.75 - 38.09
Beta	0.25
RSI	63.04
Earnings Date	May 20, 2025

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 4,963
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EBO

Financial Performance

In 2024, EBOS Group's revenue was 13.19 billion, an increase of 7.78% compared to the previous year's 12.24 billion. Earnings were 271.55 million, an increase of 7.17%.